Timing and Duration of Menopausal Hormone Treatment May Affect Cardiovascular Outcomes
- 31 March 2011
- journal article
- review article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 124 (3), 199-205
- https://doi.org/10.1016/j.amjmed.2010.09.021
Abstract
No abstract availableThis publication has 85 references indexed in Scilit:
- Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After MenopauseAmerican Journal of Epidemiology, 2009
- Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)Journal of Cardiovascular Translational Research, 2009
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJama-Journal Of The American Medical Association, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002
- 17β-estradiol inhibits oxidized low density lipoprotein-induced generation of reactive oxygen species in endothelial cellsLife Sciences, 2001
- Influence of 17β-oestradiol on blood pressure of postmenopausal women at high vascular riskJournal of Hypertension, 2001
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJama-Journal Of The American Medical Association, 1998
- Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal WomenThe New England Journal of Medicine, 1997
- Regression of Atherosclerosis in Female MonkeysArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementThe New England Journal of Medicine, 1989